The Amigo2 staining intensity scores were an average of 1.8 ± 0.4 in the liver metastatic lesions, which were significantly higher than the scores in the primary tumour lesions (0.6 ± 0.4, p < 0.01, Fig. 6b). This evidence concerns the gene AMIGO2 and neoplasm.